Follicular Lymphoma | Tumor

Epkinly Combo Reduces Risk of Progression or Death in Follicular Lymphoma

August 8th 2025, 3:00pm

Article

Epkinly with Rituxan and Revlimid, compared to Rituxan and Revlimid alone, reduced risk of progression or death by 79%.

What’s in a Name? How I Chose ‘Person’ Over ‘Survivor’ After Cancer

July 17th 2025, 9:00pm

Article

When asked to choose a word other than “survivor” to describe myself, I chose “person” because cancer does not define who I am.

Lingering Stress After Follicular Lymphoma Remission is a Challenge

April 30th 2025, 5:06pm

Article

Four years after remission from follicular lymphoma, ongoing fear of relapse, lingering symptoms, and life stressors continue to weigh heavily on me.

Remission is Not a Cure for Follicular Lymphoma, or Any Cancer

April 22nd 2025, 4:54pm

Article

It’s spring, a time for new beginnings following a cancer diagnosis; however, I have an ongoing issue that I can’t dismiss.

The Unseen Long-Term Effects After Follicular Lymphoma Treatment

March 21st 2025, 5:00pm

Article

Life after treatment for follicular lymphoma brings long-term physical and emotional challenges, including immune system impacts and lasting social effects.

Expert Explains the Side Effects of Ordspono in R/R Follicular Lymphoma

March 14th 2025, 4:00pm

Video

Dr. Deepa Jagadeesh discusses Ordspono's potential FDA approval for relapsed/refractory follicular lymphoma, highlighting its manageable toxicity and low CRS rate.

Challenging Cancer Stereotypes While Living with Follicular Lymphoma

March 7th 2025, 6:00pm

Article

Living with follicular lymphoma, I challenge common misconceptions about cancer, highlighting the unique and varied experiences of patients with cancer.

The Good and The Bad of Follicular Lymphoma

February 18th 2025, 6:00pm

Article

My annual scan showed no cancer recurrence, but revealed some minor issues related to aging and potential fibroids, requiring monitoring and follow-up.

Survivor’s Guilt: Asking, ‘Why Me?’

January 2nd 2025, 6:00pm

Article

Despite being declared cancer-free after initial treatment, I grapple with survivor's guilt, questioning why my lymphoma responded to therapy while others did not.

How Monjuvi Plus Revlimid, Rituxan Work to Treat Follicular Lymphoma

December 26th 2024, 2:00pm

Video

The treatment combination was found to reduce the risk of follicular lymphoma progression or death by 57%, a study has shown.